These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18062340)

  • 1. [Stroke. Enoxaparin sodium inhibits venous thromboembolism compared to unfractionated heparin].
    Drossbach M
    Med Monatsschr Pharm; 2007 Nov; 30(11):426. PubMed ID: 18062340
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stroke with leg paralysis -- cardioversion in atrial fibrillation: prevention of thromboembolism in risk patients].
    MMW Fortschr Med; 2006 Jun; 148(23):58-9. PubMed ID: 16826742
    [No Abstract]   [Full Text] [Related]  

  • 4. Enoxaparin for the prevention of venous thromboembolism.
    Sosis MB
    N Engl J Med; 2000 Jan; 342(2):136; author reply 137. PubMed ID: 10636757
    [No Abstract]   [Full Text] [Related]  

  • 5. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
    Zabolotskikh IB; Sin'kov SV; Klevko VA
    Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
    [No Abstract]   [Full Text] [Related]  

  • 6. Home treatment of deep venous thrombosis.
    Force RW
    J Fam Pract; 1996 Jun; 42(6):566-7. PubMed ID: 8656163
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of venous thromboembolism after ischemic stroke.
    Kase CS; Pineo GF
    Curr Opin Pulm Med; 2008 Sep; 14(5):389-96. PubMed ID: 18664967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of subcutaneous enoxaparin compared to intravenous heparin and oral phenprocoumon in the setting of cardioversion--the ACE study (Anticoagulation in Cardioversion using Enoxaparin).
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Card Electrophysiol Rev; 2003 Dec; 7(4):382-6. PubMed ID: 15071260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxaparin: in the prevention of venous thromboembolism in medical patients.
    Warner GT; Perry CM
    Am J Cardiovasc Drugs; 2001; 1(6):477-81; discussion 483-4. PubMed ID: 14728009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Care for life. Central is the patient].
    Hilpert U
    Internist (Berl); 2000 Jan; 41(1):A37. PubMed ID: 10712086
    [No Abstract]   [Full Text] [Related]  

  • 11. Is the preoperative administration of enoxaparin 40 mg necessary to optimally prevent the occurrence of venous thromboembolism after hip surgery? A subanalysis of two pooled randomized trials.
    Lassen MR
    J Thromb Haemost; 2009 May; 7(5):889-91. PubMed ID: 19245416
    [No Abstract]   [Full Text] [Related]  

  • 12. Enoxaparin for the prevention of venous thromboembolism.
    Hynson JM
    N Engl J Med; 2000 Jan; 342(2):136; author reply 137. PubMed ID: 10636756
    [No Abstract]   [Full Text] [Related]  

  • 13. The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.
    Kiphuth IC; Köhrmann M; Huttner HB; Schellinger PD
    Expert Opin Drug Saf; 2009 Sep; 8(5):585-97. PubMed ID: 19614560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for venous thromboembolism.
    Lawrence YR
    Arch Intern Med; 2004 Nov; 164(21):2386. PubMed ID: 15557421
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety.
    Levin PE
    J Bone Joint Surg Am; 1994 Nov; 76(11):1752. PubMed ID: 7962035
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction.
    Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Wienbergen H; Zahn R; Senges J
    Thromb Haemost; 2008 Jan; 99(1):150-4. PubMed ID: 18217147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary prevention of deep vein thrombosis in non-surgical patients].
    Kröger K
    Dtsch Med Wochenschr; 2005 Jul; 130(28-29):1706-10. PubMed ID: 16003608
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism.
    Deitelzweig SB; Becker R; Lin J; Benner J
    Thromb Haemost; 2008 Nov; 100(5):810-20. PubMed ID: 18989525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unfractionated heparin therapy in infants and children.
    Newall F; Johnston L; Ignjatovic V; Monagle P
    Pediatrics; 2009 Mar; 123(3):e510-8. PubMed ID: 19221154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enoxaparin versus unfractionated heparin in ST-elevation myocardial infarction.
    Sleight P; Eikelboom JW; Bassand JP
    N Engl J Med; 2006 Jun; 354(26):2830-1; author reply 2831-2. PubMed ID: 16810777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.